Which law prohibits reimporting of prescription drugs?

The Prescription Drug Marketing Act (PDMA) is the law that specifically addresses the reimportation of prescription drugs. This law was enacted to enhance the safety of prescription drugs and to ensure their proper distribution. One of its primary provisions prohibits the reimportation of prescription medications into the United States once they have left the country. This is crucial because reimported drugs may not have been subject to the same regulatory standards and oversight that ensure their safety and efficacy, posing a risk to public health.

The PDMA aims to prevent counterfeit drugs and ensure that pharmaceuticals distributed in the U.S. maintain their quality and integrity. By preventing the reimportation of drugs, this law helps to regulate the pharmaceutical supply chain and protect consumers from potentially unsafe products that may not be compliant with U.S. regulations.

Other laws mentioned, such as the Durham-Humphrey Act, the Food, Drug, and Cosmetic Act, and the Controlled Substances Act, focus on different aspects of pharmaceutical regulation, such as the distinction between prescription and over-the-counter drugs, the overall safety and efficacy of drugs, and the regulation of controlled substances, respectively. They do not specifically address the issue of reimportation as the PDMA does.